he most important information I should know about VICTRELIS?"
Blood problems. VICTRELIS can affect your bone marrow and cause low red blood cell, and low white blood cell, counts. In some people, these blood counts may fall to dangerously low levels. If your blood cell counts become very low, you can get anemia or infections.
The most common side effects of VICTRELIS in combination with peginterferon alfa and ribavirin include:
•tiredness
•nausea
•headache
•change in taste
Tell your healthcare provider about any side effect that bothers you or that does not go away.
These are not all the possible side effects of VICTRELIS. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store VICTRELIS?
•Store VICTRELIS capsules in a refrigerator at 36°–46°F (2–8°C). Safely throw away refrigerated VICTRELIS after the expiration date.
•VICTRELIS capsules may also be stored at room temperature up to 77°F (25°C) for 3 months.
•Keep VICTRELIS in a tightly closed container and away from heat.
Keep VICTRELIS and all medicines out of the reach of children.
GENERAL INFORMATION ABOUT THE SAFE AND EFFECTIVE USE OF VICTRELIS.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide.
Do not use VICTRELIS for a condition for which it was not prescribed. Do not give VICTRELIS to other people, even if they have the same symptoms that you have. It may harm them.
This Medication Guide summarizes the most important information about VICTRELIS. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about VICTRELIS that is written for health professionals.
For more information, go to www.victrelis.com or call 1-877-888-4231.
What are the ingredients in VICTRELIS?
Active ingredients: boceprevir
Inactive ingredients: sodium lauryl sulfate, microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, pre-gelatinized starch, and magnesium stearate.
Red capsule shell: gelatin, titanium dioxide, D&C Yellow #10, FD&C Blue #1, FD&C Red #40.
Yellow capsule shell: gelatin, titanium dioxide, D&C Yellow #10, FD&C Red #40, FD&C Yellow #6.
Red printing ink: shellac, red iron oxide. Yellow printing ink: shellac, povidone, titanium dioxide, D&C Yellow #10 Aluminum Lake.
This Medication Guide has been approved by the U.S. Food and Drug Administration.
Schering Corporation, a subsidiary of MERCK & CO., INC., Whitehouse Station, NJ 08889, USA
Issued: May 2011
34966419T
Trademarks depicted herein are the property of their respective owners.
Copyright © 2011 Schering Corporation, a subsidiary of Merck & Co., Inc. All rights reserved.
PRINCIPAL DISPLAY PANEL - 200 mg Carton
NDC 0085-0314-02
Victrelis™
(boceprevir) Capsules
200 mg
ATTENTION PHARMACIST:
1. Each patient is required to receive the enclosed Medication Guide
2. Remove physician insert before dispensing this package to patients.
Rx only
28 bottles x 12 capsules
REFRIGERATE
|
